Depression
Conference Coverage
Long-term effects of ketamine uncertain
“When have we ever had the ability to be sitting in front of a patient who is extremely suicidal and have an intervention that will work within [...
From the Journals
Major depression identified in almost 21% of U.S. adults
About one-third of patients with MDD in the United States go untreated.
From the Journals
Acne is linked to higher chances of major depression
More than skin deep: Acne delivers a blow to mental health.
Conference Coverage
Physicians often bypass cognition, depression screening in MS
SAN DIEGO - Physicians who did perform screening hardly ever used validated tools.
News from the FDA/CDC
Drugs identified after suicide deaths
Tests for antidepressants and alcohol were the most likely to be positive.
From the Journals
Hormone therapy may reduce depressive symptoms in early menopause
Women in the placebo arm were more than twice as likely to score at least 16 on the Center for Epidemiologic Studies–Depression Scale.
From the Journals
More evidence backs adjunctive intranasal esketamine for refractory depression
Adjunctive intranasal esketamine leads to remission of treatment-resistant depression, based on changes in MADRS total scores.
Feature
Inside the ‘mad rush’ for ketamine treatment
Treatment-resistant depression patients seem to respond well to ketamine infusions. So why are psychiatrists worried?
From the Journals
Poststroke depression raises risk of cerebrovascular death 35-fold
Depression after a stroke is deadly and should be monitored and treated.
Opinion
Physician health programs: ‘Diagnosing for dollars’?
Dr. Dinah Miller examines the value of PHPs for doctors facing burnout but warns against unfair practices sometimes found in the programs.
Commentary
Helping patients process sexual harassment
Dr. Nada L. Stotland says the most important intervention is to identify and counter the patient’s inaccurate and damaging assumptions.